NBY stock news

EMERYVILLE, Calif.--(BUSINESS WIRE)-- #NovaBay--NovaBay Pharmaceuticals launches online sales of CelleRx skin cleanser for post-aesthetic dermatology and cosmetic procedures Read more
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing Avenova® for the domestic eye care market Read more
The 875-percent rally that propelled NovaBay Pharmaceuticals, Inc. (NYSE: NBY ) shares from under 50 cents to over $3 Monday came on news of the micro-cap biotech making its Avenova eyecare product available through Amazon.com, Inc. (NASDAQ: AMZN ) without prescription. Is the product valuable enough to trigger such a strong upward move? An Antibiotic For The Eye Avenova is formulated with NovaBay's proprietary, stable and pure form of 0.1-percent hypochlorous acid used for the removal of microorganisms and debris that could lead to conditions such as meibomian gland dysfunction, dry eye and blepharitis. Bacterial eye infections account for about 85 percent of the dry eye market, according to … Full story available on Benzinga.com Read more
NovaBay Pharmaceuticals, Inc (NYSEMKT:NBY) Q1 2019 Earnings Conference Call May 09, 2019 4:30 PM ET Company Participants Bruce Voss - Investor Relations, LHA Ju Read more
NovaBay Pharmaceuticals, Inc (NYSEMKT:NBY) Q4 2018 Results Earnings Conference Call March 28, 2019 04:30 PM ET Company Participants Bruce Voss - IR, LHA Justin Read more

12:07pm, Wednesday, 27'th Mar 2019
Read more

10:24am, Wednesday, 27'th Mar 2019
Read more
Change of 19.69% for Novabay Pharmaceuticals Inc (NYSEAMERICAN:NBY)'s shorted shares was recorded. It was issued in March by FINRA the 31,400 shorted shares on Read more
Doing the necessary homework, investors have a wealth of information about publically traded stocks. Figuring out which ones are going to steadily outperform can be a tricky task. Many investors opt t Read more
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) is set to post its quarterly earnings results after the market closes on Thursday, March 28th. Analysts expect NovaBay Pharmaceuticals to post earnings of ($ Read more
Shaers of NovaBay Pharmaceuticals, Inc. (:NBY) have been recommended as a long term growth pick according to Beta Research. With the firm’s stock price currently trading around $1.40, the firm has p Read more
Taking a closer look at technical signals for Novabay Pharmaceuticals (NBY), we can see that the short-term moving average Hilo channel is presently Hold. This indicator calculates the moving average Read more
Bargain stock hunters have honed in their attention of late on shares of NovaBay Pharmaceuticals, Inc. (:NBY). The stock is currently valued at $1.40 after moving 0.00% in the most recent session and Read more
When investors are recalibrating their portfolios they should take a look at current volatility levels and the target weight calculation of a given stock. NovaBay Pharmaceuticals, Inc. (AMEX:NBY) has Read more
A “pivot point” is a technical analysis indicator used to find the overall trend of the market over different time periods. A pivot point is simply the average of the high, low and closing prices Read more

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

Proudly Made At